Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
17 May 2023 Brain cell death in rare disease Wolfram syndrome linked to mitochondrial defects The Sarkar and Barrett labs have defined the molecular basis of neurodegeneration in Wolfram Syndrome patients carrying the WFS1 gene mutation.
15 May 2023 £2m boost for study to detect early stage ovarian cancer NHS Cancer Programme funding will see an advanced test used at GP surgeries in the West Midlands to diagnose early-stage ovarian cancer.
12 May 2023 Cannabinoid-based drug trial for brain tumours begins Patients with aggressive brain tumours may be able to take part in a new trial of a cannabinoid-based drug, coordinated by the University of Birmingham.
12 May 2023 Birmingham cancer researchers show how reduced MYB levels promote malignant blood cell development Study showed that low levels of the MYB protein can be linked to the development of rare blood cancers.
10 May 2023 AI-powered personalised medicine tool for hypertension being developed Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.
04 May 2023 Incurable blood cancer trial finds new drug better than current second line treatments Cancer Research UK Clinical Trials Unit-sponsored trial found new drug better for treating rare cancer for patients not responding to first line treatment